The Journal of Neuroscience, 2001, 21:RC149:1-5
RAPID COMMUNICATION
Free 3-Nitrotyrosine Causes Striatal Neurodegeneration In
Vivo
Michael J.
Mihm,
Brandon L.
Schanbacher,
Benjamin L.
Wallace,
Lane J.
Wallace,
Norman J.
Uretsky, and
John Anthony
Bauer
Division of Pharmacology, College of Pharmacy, The Ohio State
University, Columbus, Ohio 43210
Peroxynitrite formation has been demonstrated in several
neurodegenerative disorders; thus far, protein nitration and consequent alterations in protein function are implicated as mechanistic events.
Free 3-nitrotyrosine (free-3NT) is also elevated in these settings; a
neurotoxic role for this modified amino acid has not been investigated.
We tested the hypothesis that free-3NT is neurotoxic in
vivo, using a mouse model of striatal degeneration. The
neurodegenerative effects of the dopaminergic neurotoxin
6-hydroxydopamine (6-OHDA) (unilateral intrastriatal injection, 64 nmol) were compared with free-3NT (32 nmol) or free-tyrosine
(free-TYR) (32 nmol). 6-OHDA-treated mice exhibited significant
ipsilateral turning behavior after D-amphetamine challenge,
indicative of unilateral striatal injury (ipsilateral-contralateral
turning differential, 21.1 ± 6.8). Significant turning behavior
was also observed in free-3NT-treated mice but not in
free-tyrosine-treated mice (free-3NT, 16.0 ± 3.9; free-TYR,
1 ± 2.7; p < 0.01). Immunohistochemistry was
used to evaluate striatal tyrosine hydroxylase (TH) content. 6-OHDA or free-3NT treatment caused severe reductions in TH immunoreactivity in
injected striata compared with the contralateral hemisphere (injected/contralateral immunoreactivity ratio: 6-OHDA, 0.23 ± 0.07; free-3NT, 0.49 ± 0.02). Free-tyrosine treatment had no
effect (1.03 ± 0.09). Turning behavior was correlated with
striatal TH ratio (p < 0.01). Furthermore,
we observed a striking unilateral reduction in TH-positive cell body
counts in the substantia nigra pars compacta of 6-OHDA- and
free-3NT-treated mice (injected/contralateral cell count ratio: 6-OHDA,
0.40 ± 0.04; free-3NT, 0.59 ± 0.02). Free-tyrosine
treatment had no effect (1.05 ± 0.04). No evidence for increased
striatal protein incorporation of 3NT was observed in any treatment
group. These data represent the first evidence that free-3NT can elicit
neurodegenerative effects in vivo; free-3NT may have a
causal role in neurodegenerative conditions.
Key words:
peroxynitrite; 3-nitrotyrosine; neurodegeneration; Parkinson's disease; nitration; nitric oxide
Copyright © Society for Neuroscience 0270-6474//$05.00/0